FacebookLinkedinRSSTwitterYoutubeFacebookLinkedinRSSTwitterYoutube

Sign in

Welcome! Log into your account

Forgot your password? Get helpPrivacy Policy

Password recovery

Recover your password

A password will be e-mailed to you.

GEN – Genetic Engineering and Biotechnology NewsHomePodcastsGENcast

Small Molecules, Big Expectations: How CDMOs Are Helping Sponsors Navigate Complexity, Speed,...

Credit: wera Rodsawang / Getty Images

Credit: wera Rodsawang / Getty Images

Small molecules continue to play a major part in pharmaceutical development, but increasing molecular complexity, accelerated timelines, and evolving manufacturing and regulatory requirements are creating new challenges for the industry.

In this GEN Podcast—part 2 in a 3-part series—a trio of experts from SK Pharmteco discuss how CDMOs are helping biopharma companies navigate critical areas including scale-up, technology transfer, advanced manufacturing, automation, sustainability, the emergence of AI, and supply chain reliability. The discussion explores practical strategies for improving development efficiency while supporting quality, scalability, and long-term commercial success.

Podcast Guests:

Steve Barr, PhD

Head of Small Molecule Business Unit

and VP Global Alliances

SK pharmteco

Darryl Ratty

Executive Director of Global ESG

ESG (Environmental, Social and Governance)

SK pharmteco

Bill DuBay

Vice President,

Global Research and Development

SK pharmteco

Produced with support from:

GENcastMultimediaSponsoredSponsored PodcastsArtificial intelligenceDrug development (Research and development)Regulatory policiesSmall moleculesSK pharmteco

Copyright © 2026 Sage Publications or its affiliates, licensors, or contributors. All rights reserved, including those for text and data mining and training of large language models, artificial intelligence technologies, or similar technologies.

MORE STORIES

GENcast: Explore, Learn, and Collaborate on Next-Generation Bioprocessing

GENcast: Cancer Diagnostics and PD-L1